MAPK3 and neoplasm: MSCs may influence tumour angiogenesis through mechanisms involving increased VEGF secretion, which activates the ERK1/2 pathway [68], or via the transfer of oncogenic miRNAs that affect various processes in tumour cells, such as inhibition of PTEN, inhibition of apoptosis or induction of macrophage type M2 polarization [70,71].